GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease

Anaerobic glycolysis
DOI: 10.1016/j.molmet.2021.101180 Publication Date: 2021-02-07T06:08:37Z
ABSTRACT
Astrocytes actively participate in energy metabolism the brain, and astrocytic aerobic glycolysis disorder is associated with pathology of Alzheimer's disease (AD). GLP-1 has been shown to improve cognition AD; however, mechanism remains unclear. The objectives this study were assess GLP-1's glycolytic regulation effects AD reveal its neuroprotective mechanisms. Morris water maze test was used evaluate liraglutide (an analog GLP-1) on 4-month-old 5×FAD mice, a proteomic analysis Western blotting profile changes. We constructed an model by treating primary astrocytes Aβ1-42. levels NAD+ lactate examined, oxidative assessed Seahorse examination. Astrocyte-neuron co-culture performed astrocytes' neuronal support. improved mice enhancing reducing phosphorylation (OXPHOS) stress brain. also alleviated Aβ-induced declines astrocytes, which resulted reduced OXPHOS reactive oxygen species (ROS) production. involved activation PI3K/Akt pathway GLP-1. Elevation astrocyte cells' support neurons promoted survival axon growth. Taken together, we revealed capacity regulate glycolysis, providing mechanistic insight into one roles for feasibility treatments AD.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (51)
CITATIONS (116)